학술논문
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
Document Type
Article
Author
Source
In The Lancet Respiratory Medicine August 2021 9(8):829-839
Subject
Language
ISSN
2213-2600